Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 982,021 | 739,016 | 563,948 | 449,538 | 373,653 |
| Cost of Goods | 349,007 | 289,799 | 227,052 | 156,325 | 122,912 |
| Gross Profit | 633,014 | 449,217 | 336,896 | 293,213 | 250,741 |
| Operating Expenses | 1,070,269 | 893,610 | 901,673 | 837,916 | 662,654 |
| Operating Income | -437,248 | -443,594 | -564,725 | -544,378 | -411,001 |
| Interest Expense | 3,897 | 2,581 | 2,578 | 2,577 | 2,577 |
| Other Income | 23,605 | 11,086 | 88,539 | -106,494 | 29,108 |
| Pre-tax Income | -417,540 | -435,089 | -478,764 | -653,449 | -384,470 |
| Income Tax | -1,263 | 1,284 | 685 | 1,139 | 300 |
| Net Income Continuous | -416,277 | -436,373 | -479,449 | -654,588 | -384,770 |
| Minority Interests | N/A | N/A | N/A | N/A | 20,900 |
| Net Income | $-416,277 | $-436,373 | $-479,449 | $-654,588 | $-405,670 |
| EPS Basic Total Ops | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 |
| EPS Basic Continuous Ops | -3.32 | -3.56 | -4.28 | -6.41 | -3.80 |
| EPS Diluted Total Ops | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 |
| EPS Diluted Continuous Ops | -3.32 | -3.56 | -4.28 | -6.41 | -3.80 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.56 | -4.28 | -6.41 | -4.00 |
| EBITDA(a) | $-403,389 | $-407,981 | $-535,396 | $-501,252 | $-373,317 |